Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Enteropathic arthropathy

Introduction

Overview

Overview

Enteropathic arthropathy or Enteropathic arthritis refers to acute or subacute arthritis in association with or as a reaction to an enteric (usually colonic) inflammatory condition.

Classification

Classification

  • Peripheral arthritis
  • Type I Arthropathy
    • Less than five joints involved
    • Acute
    • Less than 10 weeks
    • Asymmetrical
    • Shoulder, hips and knee joints are involved
  • Type II Arthropathy
    • More than five joints involved
    • Chronic
    • Months to years
    • Symmetrical
    • Small joints are involved.
Pathophysiology

Pathophysiology

Risk factors

Risk factors

Causes

Causes

Differential diagnosis

Differential diagnosis

The Differential diagnosis of enteropathic arthritis are as follows:

Signs and Symptoms

Signs and Symptoms

Physical Examination

Physical Examination

The physical examination findings of a patient with Enteropathic arthropathy include:[1][2][3][4]

General Appearance

Vitals

HEENT

Cardiovascular System

Gastrointestinal System

  • Abdominal tenderness in the right lower quadrant
  • Abdominal distension

Skin

Musculoskeletal System

Laboratory Findings

Laboratory Findings

The laboratory tests for the Enteropathic arthritis are as follows:[5][6]

Laboratory tests Findings
CBC
Iron studies
Serum Vit B12
  • Normal or low
[null Serum folate]
  • Normal or low
CMP
CRP and ESR
  • Elevated
Stool testing
  • Negative for infectious elements
Yersinia serology
  • Negative
Diagnostic test of choice

Diagnostic test of choice

Medical Therapy

Medical Therapy

Non-Pharmacological therapy

Pharmacological therapy

References

References

  1. โ†‘ Ha F, Khalil H (2015). “Crohn’s disease: a clinical update”. Therap Adv Gastroenterol. 8 (6): 352โ€“9. doi:10.1177/1756283X15592585. PMCย 4622286. PMIDย 26557891.
  2. โ†‘ Wilkins T, Jarvis K, Patel J (2011). “Diagnosis and management of Crohn’s disease”. Am Fam Physician. 84 (12): 1365โ€“75. PMIDย 22230271.
  3. โ†‘ Donnellan CF, Yann LH, Lal S (2013). “Nutritional management of Crohn’s disease”. Therap Adv Gastroenterol. 6 (3): 231โ€“42. doi:10.1177/1756283X13477715. PMCย 3625021. PMIDย 23634187.
  4. โ†‘ Baumgart DC (2009). “The diagnosis and treatment of Crohn’s disease and ulcerative colitis”. Dtsch Arztebl Int. 106 (8): 123โ€“33. doi:10.3238/arztebl.2009.0123. PMCย 2695363. PMIDย 19568370.
  5. โ†‘ Kaila, B. (2005). “The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn’s disease and predicting inflammatory disease”. The Canadian Journal of Gastroenterology. 19 (12): 717โ€“21. PMID 16341311. Retrieved 2006-07-02. Unknown parameter |month= ignored (help); Unknown parameter |coauthors= ignored (help)
  6. โ†‘ Israeli, E. (2005). “Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease”. Gut. 54 (9): 1232โ€“6. doi:10.1136/gut.2004.060228. PMID 16099791. Unknown parameter |coauthors= ignored (help); Unknown parameter |month= ignored (help)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]